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The detailed understanding of adult tissue stem cells has significance for both regenerative medicine and
oncology. This perspective will discuss how major advances in our ability to identify and monitor these cells,
which include genetic lineage tracing, FACS purification, and robust in vitro clonogenic assays, have
changed our view of their roles in many organs. Label retention and quiescence are no longer considered
obligatory stem cell features. Furthermore, some tissues have more than one type of stem cell, each used
in only particular situations of regenerative stress. Thus, there is no ‘‘one size fits all’’ adult tissue stem cell
paradigm.Spurred by the excitement surrounding the potential of pluripo-
tent stem cells in regenerative medicine (Takahashi et al.,
2007), interest in tissue-specific adult stem cells also increased
significantly since the inception of this journal. A detailed under-
standing of how organs maintain and repair themselves in the
postnatal organism is obviously required in order to properly
utilize the derivatives of pluripotent cells in therapy. In addition,
it is conceivable that the ability to control and manipulate tissue
stem cells in situ may obviate the need for exogenous cell trans-
plantation altogether. There is much evidence that tissue-
resident stem cells may be the origin of malignant tumors (Barker
et al., 2009). Therefore, knowing the mechanisms that turn stem
cells into cancer stem cells or understanding how cancers
derived from differentiated cells acquire stem cell characteristics
would probably yield targets for therapy. Although it would be
difficult to comprehensively cover all of the advances recently
made in our understanding of the many different kinds of tissue
stem cells, there are some common themes that apply broadly
and these will be discussed herein.
Stem Cells versus Progenitors: Not Simply a Semantic
Distinction
Perhaps because of its popularity with the lay public and funding
agencies, the term ‘‘stem cell’’ is used liberally and often indis-
criminately. However, despite much progress, the existence of
true stem cells has to date been shown for only few adult tissues
when the strict criterion of extensive clonal self-renewal (van der
Kooy and Weiss, 2000; Weissman et al., 2001) is used. This
widely accepted stem cell definition was derived from the hema-
topoietic field where in vivo transplantation assays are available
to assess replicative potential. Similar in vivo reconstitution
assays do not yet exist for many adult tissues and thus it is not
possible to clearly prove self-renewal in those organs by this
classic approach. In some rapidly regenerating tissues—most
notably the intestine—clonal marking techniques can prove
life-long self-renewal in the absence of transplantation and firmly
establish the identity of stem cells (Figure 1). However, in many
tissues the existence of true stem cells remains yet to be fully
proven and the term ‘‘progenitor’’ is more appropriate to
describe the cells that have been found to date. Like true stem
cells, progenitors often are multipotential and may give rise toseveral different mature lineages. However, they can be distin-
guished from true stem cells by the fact that clonal labeling is
transient and does not last for the life of the animal (Figure 1C).
In contrast, true stem cells will produce labeled offspring perma-
nently (Figure 1A). Extensive self-renewal in culture may repre-
sent an in vitro artifact and does not conclusively prove that
the cell in question truly is a stem cell in vivo. The distinction is
not just semantic because the limited self-renewal of progenitors
may signify restricted regenerative capacity of a particular tis-
sue, particularly in the setting of chronic injury or aging. Although
the existence of self-renewing stem cells in highly regenerative
organs has been established for some time now (Mackenzie
and Bickenbach, 1985; Potten and Hendry, 1975), the precise
identity, molecular regulation, and anatomic location of these
cells in organs such as colon (Barker et al., 2007), small intestine
(Barker et al., 2007), stomach (Barker et al., 2010), breast
(Shackleton et al., 2006; Stingl et al., 2006), and skin (Snippert
et al., 2010a) were described only fairly recently.
In the intestine, these breakthroughs were made by using
genetic lineage tracing, a strategy originally devised by develop-
mental biologists (Kretzschmar and Watt, 2012). Although it has
been generally challenging to find highly specific markers for
adult tissue stem cells, methods such as genome-wide assess-
ment of gene expression in highly purified cell populations have
suggested candidate genes (Barker et al., 2007). These loci can
be used to restrict marker gene expression to the cells of interest
and their progeny, thereby allowing analysis of self-renewal and
potency in vivo. The results of these kinds of studies have been
surprising in some cases, most notably in the small intestine,
where the cell located in the crypt at the +4 position was long
thought to be the true and only stem cell (Potten et al., 2009;
Potten and Hendry, 1975). However, lineage tracing of cells
expressing the Wnt target Lgr5 unambiguously showed that
slender cells at the bottom of the crypt, which are clearly distinct
from the +4 cells, also act as stem cells (Barker et al., 2007; Snip-
pert et al., 2010b). Lgr5+ cells give rise to all of the differentiated
cells types of the intestinal villus and divide hundreds of times
during the life of the animal. Highly specific stem cell markers
such as Lgr5 are still missing for many other tissues and their
identification should be a high priority for the field. Markers
specific for stem cells and progenitors in organs such as lung,Cell Stem Cell 10, June 14, 2012 ª2012 Elsevier Inc. 685




Figure 1. Lineage Tracing in Adult Tissue Stem Cell Systems
(A) A self-renewing stem cell is labeledwith a specificmarker (green). All cells in
the hierarchy are permanently marked in long-term follow up.
(B) Specific labeling of mature, differentiated cells. If these cells are replaced
by a mature stem/progenitor, the label will disappear from the mature pop-
ulation with time.
(C) A progenitor, not capable of indefinite self-renewal, is labeled. After short











Figure 2. Schematic of a System with Two Stem Cells
Both the active and reserve stem cells are capable of self-renewal. In most
situations, including normal tissue maintenance, only the active stem cell
contributes to renewal of the tissue, dividing continuously and giving rise to an
amplifying compartment and mature cells. When the active stem cell is lost,
a normally dormant (label-retaining) reserve stem cell is activated and
replenishes the active stem cell compartment.
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formed during adult organ maintenance and repair and would
probably resolve some of the current controversies. Specific
stem cell markers would also allow the determination of whether
cancers originate from that population, as shown for Lgr5+ colon
stem cells (Barker et al., 2009).
Label Retention and Quiescence: Stem Cell Markers of
the Past?
Perhaps the most generally significant consequence of the
discovery of the Lgr5+ intestinal stem cell is our changed view
of quiescence as an essential property of tissue stem cells. Label
retention was once considered a hallmark of tissue stem cells
(Clarke et al., 2003; Duvillie´ et al., 2003; Mackenzie and Bicken-
bach, 1985; Morris and Potten, 1994; Terskikh et al., 2011). In
order to identify label-retaining cells (LRCs), replicating DNA
was labeled by administration of radioactive thymidine or BrdU
for a prolonged period, followed by an even longer washout686 Cell Stem Cell 10, June 14, 2012 ª2012 Elsevier Inc.time. Tissues were then stained and cells that still retained their
labels months or years after labeling were considered to be stem
cells (Potten andHendry, 1975). This paradigmwas based on the
notion that stem cells should persist in tissues and divide only
rarely to protect their genome.Work in the epidermis had already
clearly shown that LRC were not the only stem cells in skin
(Claudinot et al., 2005; Li and Clevers, 2010), but the very rapid
rate of division in Lgr5+ intestinal stem cells plainly demonstrated
that quiescence and label retention are not inherent properties of
all tissue stem cells.
What then is the role of the label-retaining +4 intestinal stem
cell (Potten et al., 2009)? Further investigation of this topic has
revealed another important new concept in tissue stem cell
biology: there can be more than one type of stem cell (Figure 2;
Li and Clevers, 2010). Although it is clear that Lgr5+ stem cells
are responsible for self-renewal during normal homeostasis,
certain injuries, particularly irradiation, result in the activation
of the label-retaining +4 stem cell (Takeda et al., 2011; Tian
et al., 2011; Yan et al., 2012). Activated +4 cells are able to
produce new Lgr5+ cells, both in vivo and in vitro. Hence, the
+4 position intestinal stem cell is the prototype of a facultative
tissue stem cell, called upon only in very specific circumstances
(Figure 2). Although the +4 cells are normally quiescent, lineage
tracing with Hopx as a specific marker for this population has
shown that the relationship between the two stem cells is bidi-
rectional (Takeda et al., 2011). Depending on the situation,
Lgr5+ intestinal stem cells can produce Hopx+ +4 cells and
vice versa (Figure 2).
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skin. Here the classic LRC—once thought to be the only stem
cell—resides in the bulge of the hair follicle. Normally quiescent,
these cells can spring into action after treatment with phorbol
esters (Cotsarelis et al., 1990). Although bulge LRCs clearly
can act as stem cells, an independent population, labeled by
Lgr6, cycles continuously and renews all skin lineages for the
life of the animal (Jaks et al., 2010; Snippert et al., 2010a).
Evidence for facultative stem cells also exists in several other
tissues, including those with slow turnover in the adult such as
the liver (Dorrell et al., 2011; Duncan et al., 2009) or muscle
(Tedesco et al., 2010). In the liver, replication of mature hepa-
tocytes is responsible for tissue maintenance and also many
injury responses (Michalopoulos, 2010). However, normally
dormant facultative adult stem cells can be activated by certain
injuries (Furuyama et al., 2011; Malato et al., 2011), proliferate,
and give rise to multiple differentiated lineages until the tissue
is restored. By definition, facultative stem cells are quiescent
and thus it appears that the label retention methodology is
particularly well suited to identify this kind of stem cell.
Because the utilization of more than one progenitor cell
compartment during normal tissue maintenance and injury
has now been shown in multiple examples, it will be important
to carefully evaluate multiple kinds of clinically relevant injury
paradigms in each tissue. Different physiological and patholog-
ical stressors might very well give significantly different
answers regarding the identity and molecular regulation of
the resident stem cell.
In Vitro Clonogenic Assays: Faithful or Misleading?
When lineage tracing tools and/or transplantation assays are not
available, clonal self-renewal in vitro coupled with in vitro differ-
entiation can be used as a surrogate to identify putative stem/
progenitor cells. If these assays are combined with cell fraction-
ation methods such as FACS, it becomes possible to identify the
most clonogenic cells and interrogate their properties, including
the signals required for self-renewal. After clonogenic growth,
differentiation protocols can be tested to determine the signals
that govern maturation. Much progress has been made in this
area for many different tissue stem cell systems. New surface
markers have been developed and colony-forming assays now
exist for most tissues. Because genetic lineage tracing is not
possible in humans and cell transplantation assays are not avail-
able for many tissues, clonogenic growth is also used as an
assay for human tissue stem cells, even when their murine coun-
terparts are tractable by the other methods. In many tissues, for
example the liver and intestine, there is excellent congruence
between the clonogenic assays and lineage tracing (Dorrell
et al., 2011; Sato et al., 2009). However, there are also several
examples where in vitro assays produce different answers than
the more definitive in vivo genetic lineage tracing. Normal pros-
tate gland epithelium contains two main differentiated cell types:
luminal columnar epithelium and basal cells below the luminal
layer (Wang et al., 2009). In the mouse prostate, Lin/Sca-1+/
CD49f+ cells are most clonogenic in sphere-forming assays
and most capable of forming prostate tissue in renal grafts
(Lawson et al., 2007), indicating that prostate stem cells reside
in the basal layer. Using similar assays, human prostate stem
cells are also thought to be basal in nature (Garraway et al.,2010). Interestingly, however, genetic lineage tracing experi-
ments using the transcription factor Nkx3.1 as a marker indicate
that a completely distinct, rare luminal epithelial cell is respon-
sible for regenerating the prostate after androgen deprivation
(Wang et al., 2009). Once again, these findings suggest that there
may be more than one type of stem cell in this tissue. However, it
is also possible that the clonogenic basal cells are not stem cells
in vivo at all and that the in vitro assay does not faithfully reflect
tissue biology. Similarly, in vitro experiments had long suggested
that the ducts of the adult pancreas might be able to produce
endocrine b cells by neogenesis. Several publications agree
that ducts are the progenitors for the acinar exocrine pancreatic
cells (Criscimanna et al., 2011; Furuyama et al., 2011; Kopp et al.,
2011b; Xu et al., 2008), but there is discordance in regards to the
origin of b cells. When definitive genetic lineage tracing tools
were used to specifically identify the progeny of pancreatic ducts
in vivo (Furuyama et al., 2011; Kopp et al., 2011b), it was clearly
shown that they do not ever produce new b cells, even after
extensive injury such as duct ligation or b cell ablation (Kopp
et al., 2011a). These cautionary tales illustrate that in vitro clono-
genic assays can be misleading and that cells identified in this
fashion need to be validated as true tissue stem cells by more
definitive methodology.
Tissues with No Need for Stem Cells?
One of the most interesting recent findings is that some adult
tissues do not appear to have a stem cell at all, which may
explain their vulnerability to cell loss. Most notable in this regard
is the endocrine pancreas. This tissue also exemplifies an inter-
esting variation of the genetic lineage tracing methodology. If
a specific stem cell marker is not available, one can determine
the existence or assess the importance of stem cells by using
a marker that is highly specific for their mature, differentiated
progeny (Figure 1B). In the case of the endocrine pancreas
such a marker is insulin, which is expressed only in b cells. Adult
b cells can be genetically labeled and their fate, and that of their
derivatives, followed over time (Dor et al., 2004; Malato et al.,
2011). This kind of lineage tracing experiment allows asking
the question whether unlabeled cells contribute to the lineage
over an extended period. Emergence of unlabeled b cells would
indicate the presence of a stem cell or progenitor. Unexpect-
edly, such experiments based on labeling of insulin+ cells
showed that b cells did not derive from insulin stem cells or
progenitors in postnatal life during normal tissue maintenance
(Dor et al., 2004). Instead, newly born b cells were generated
only by division of pre-existing b cells. This observation has
challenged the previous notion that the adult pancreas harbors
b cell stem cells or progenitors. Similar experiments were
done for the liver utilizing transthyretin as a marker of mature
hepatocytes (Malato et al., 2011). The experiments showed
that liver homeostasis in adult mice is achieved by hepatocyte
replication similar to the b cell situation (Dor et al., 2004). Unlike
the pancreas, however, specific injuries revealed the emergence
of unlabeled hepatocytes, which must be derived from faculta-
tive stem cells or progenitors. Lineage tracing with mature
markers nicely complements genetic marking studies using
stem cell-specific genes. The use of both approaches in the
same tissue increases the confidence in models of tissue stem
cell behavior if the results are congruent (Dorrell et al., 2011;Cell Stem Cell 10, June 14, 2012 ª2012 Elsevier Inc. 687
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Shin et al., 2011). Thus, the liver has now been firmly added to
the list of organs that harbors an adult tissue stem cell. Interest-
ingly, similar certainty is still lacking for some very important
tissues. For example, there currently is no convincing evidence
that the podocytes of the renal glomerulus have an adult
progenitor.
Niches
Once a stem cell is identified and localized, it becomes possible
to study the extrinsic regulatory signals produced by the local
microenvironment, the niche (reviewed in Lander et al., 2012).
This particular aspect of tissue stem cell biology is especially
important for cancer. Many of the factors that impact healthy
adult tissue stem cells also play a role in tumor self-renewal
(Burness and Sipkins, 2010; Cabarcas et al., 2011). Each tissue
and each stem cell uses different niche signals, but the Wnt/
b-catenin pathway has received the most attention overall and
has been found to play a key role in the intestine, skin (Haege-
barth and Clevers, 2009), and breast (Tanos and Brisken,
2008). The full elucidation of interactions between niches and
stem cells will undoubtedly be one of the main topics of tissue
stem cell research in the future. Therapeutic opportunities
abound in this area because molecules to block or activate
extrinsic signaling pathways could be used to affect the behavior
of particular stem cells, both in terms of ablation (cancer) and
expansion (tissue repair). An intriguing application of the knowl-
edge garnered from the study of the intestinal stem cell niche is
the bacterial delivery of b-catenin-lowering transkingdom RNAi
to lower the risk of cancer in familial adenomatosis of the colon
(FAP) (Xiang et al., 2009).
miRNAs: Regulators of Stem Cell Quiescence
and Self-Renewal
Our newfound ability to isolate and highly purify tissue stem
cells in some organs has also opened up the study of intrinsic
signals. In addition to transcription factors, microRNAs
(miRNAs) have emerged as key players in determining the fate
of tissue stem cells and their progeny. Improved methods for
profiling miRNAs in very small numbers of cells (Smith and Mur-
ray, 2012) have facilitated identification of major changes in
specific miRNAs as stem cells are activated and embark on
differentiation (Yi and Fuchs, 2011). A single microRNA,
miR-489, maintains satellite cells (the facultative stem cells of
skeletal muscle) in quiescence and its downregulation results
in satellite cell activation (Cheung et al., 2012). Conversely,
miR-1 and miR-206 are upregulated when satellite cells differ-
entiate and suppress Pax7 message, a transcription factor
that is important for maintaining satellite cell quiescence
(Chen et al., 2010). In addition to their important roles in somatic
stem cell activation and differentiation, miRNAs can also be
important for self-renewal. Recent examples include miR-205,
which is highly expressed in mammary stem cells and can drive
self-renewal when overexpressed (Greene et al., 2010; Ibarra
et al., 2007). In the skin, inducible overexpression of miR-125b
in adult stem cells produces an increased stem cell pool (Zhang
et al., 2011). miRNAs also regulate the regenerative abilities of
mature cells, such as recently shown for miR-21 in hepatocytes
(Ng et al., 2012).688 Cell Stem Cell 10, June 14, 2012 ª2012 Elsevier Inc.Conclusions and Future Directions
The past 5 years have seen the transition from fairly nonspecific
methods for the identification of tissue stem cells such as label
retention to more definitive methodology, especially genetic
lineage tracing. The ability to prospectively isolate tissue stem
cells with high purity and to visualize them within their niches is
producing incisive insights into the intrinsic and extrinsic (niche)
regulation of their behavior. Recent progress in intestinal stem
cell biology has been particularly impressive and it can be hoped
that other important organ systems such as the lung, liver, and
kidney will follow suit in the near future.ACKNOWLEDGMENTS
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